The first hypothesis of the study is that substituting fentanyl by esmolol and metoprolol during general anesthesia for patients undergoing mastectomy will result in less pain and less narcotic consumption in the recovery room. The investigators will also verify the impact of that substitution on nausea and vomiting, on the time spent in the recovery room and on chronic postsurgical pain (3 and 6 months). Finally, the investigators will see the impact on breast cancer recurrence 5 years after the surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
84
Use of esmolol and metoprolol compared to use of fentanyl for hemodynamic control during general anesthesia. At induction, fentanyl (2 mcg/kg) is replaced by esmolol (1 mg/kg). During the case, with a standardised anesthesia, response to surgical stimulation will be medicated either by fentanyl (50 mcg aliquot) or metropolol (2.5 mg), for a maximum of 6 doses. After this, fentanyl will be given unblindly.
esmolol is used at induction and lopressor during surgery instead of fentanyl in response to surgical stimulation.
Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
Postoperative consumption of narcotic in recovery room
Time frame: Immediately after surgery
Pain level in recovery room
Time frame: immediately after surgery
Occurence of nausea and vomiting in the recovery room
Time frame: immediately after surgery
Time spent in recovery room
Time frame: immediately after surgery
Chronic post-surgical pain
Time frame: 3 and 6 months
Reccurence of breast cancer
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.